Metformin exhibits analgesic activity in neuronal cell models and CFA-induced inflammatory pain in mice
Molecular Pain · 2026-06 · 22
DOI: 10.1177/17448069261452893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pain, online erschienen am 14.05.2026. Verfasst von Thi-Chau-Loan Phan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Applied Science and Engineering, Fu Jen Catholic University, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: Metformin, Analgesics, Pain, Inflammation. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Inflammatory pain is mediated by complex interactions between immune signaling and sensory neurons, with prostaglandin E2-dependent pathways playing a central role in nociceptive sensitization. Metformin, a first-line antidiabetic drug, has emerged as a potential non-opioid analgesic due to its pleiotropic anti-inflammatory and neuroprotective properties. In this study, we investigated the analgesic effects of metformin using both an in vitro neuronal sensitization model and an in vivo model of inflammatory pain. In SH-SY5Y neuronal cells, PGE2 exposure significantly reduced Na + /K + -ATPase activity and increased intracellular cAMP levels. Post-treatment with metformin restored Na + /K + -ATPase activity and suppressed cAMP elevation in a concentration-dependent manner. In vivo, metformin produced dose-dependent analgesia in mice with complete Freund’s adjuvant-induced inflammatory pain, with 0.1 g/kg/day significantly increasing hind paw withdrawal thresholds. Molecular analyses revealed significant downregulation of pain-associated proteins TRPV1 and NaV1.7 in metformin-treated groups, supported by both Western blot and immunohistochemical findings. Histological examination further demonstrated reduced inflammatory cell infiltration and improved tissue recovery. Collectively, these findings indicate that metformin alleviates inflammatory pain by modulating neuronal excitability and inflammatory signaling pathways, highlighting its potential as a non-opioid therapeutic candidate for inflammatory pain management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Applied Science and Engineering, Fu Jen Catholic University, New Taipei City, Taiwan.
- School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
- Department of Life Science, Fu Jen Catholic University, New Taipei City, Taiwan.
ORCID-Profile: Yao-Jen Liang
Zitieren
APA
Phan, T. C., Chang, J. T., Ma, C. H., & Liang, Y. J. (2026). Metformin exhibits analgesic activity in neuronal cell models and CFA-induced inflammatory pain in mice. Molecular Pain, 22. https://doi.org/10.1177/17448069261452893
Vancouver
Phan TC, Chang JT, Ma CH, Liang YJ. Metformin exhibits analgesic activity in neuronal cell models and CFA-induced inflammatory pain in mice. Molecular Pain. 2026;22. doi:10.1177/17448069261452893
BibTeX
@article{Phan2026,
author = {Phan, Thi-Chau-Loan and Chang, Jui-Ting and Ma, Chih-Hsiang and Liang, Yao-Jen},
title = {Metformin exhibits analgesic activity in neuronal cell models and CFA-induced inflammatory pain in mice},
journal = {Molecular Pain},
year = {2026},
volume = {22},
doi = {10.1177/17448069261452893}
}
EUVIMED